Related by context. All words. (Click for frequent words.) 70 Receives Milestone Payment 70 Licenses Novel 69 Announce Licensing Agreement 69 Initiates Phase II 69 Begins Dosing 68 Announce Collaboration Agreement 67 Initiates Phase III 67 Initiates Clinical Trial 67 Announce License Agreement 67 Announces Licensing Agreement 66 Announce Merger Agreement 66 Completes Patient Enrollment 66 Syntonix Pharmaceuticals 66 Initiates Clinical 65 Reports Preclinical Data 65 Welcomes Analyst Initiation 65 AUDIO PROVIDED BY 65 Submits IND 65 Presents Preclinical Data 65 Files IND 65 WeissComm Partners +#-#-#-# 65 IG HCR ;) CO 65 Initiates Dosing 64 Presents Preclinical 64 Presents Positive 64 Receive Milestone Payment 64 Successfully Completes Tender Offer 64 Therapeutic Competitors Companies 64 Submits Biologics License Application 64 Initiates Enrollment 64 Announces License Agreement 64 Extends Collaboration 64 Files Shelf Registration Statement 64 Completes Enrollment 64 Receives Orphan Drug 63 BioSante Pharmaceuticals Announces 63 Develop Novel 63 Inc. Nasdaq OXGN 63 Bayhill Therapeutics 63 Enrolls First 63 Receives Approvable Letter 63 Sign License Agreement 63 Amends Agreement 63 Receives Orphan Drug Designation 63 Signs License Agreement 63 Collaborators Present 63 Presents Positive Preclinical 63 Completes Dosing 63 SVP Exercises Options 62 Genentech sanofi aventis 62 Jumps Higher 62 Reveals Positive 62 Q3 Loss Narrows 62 Completes Merger With 62 Initiates Phase 2b 62 Collaborators Publish 62 Appoints Seasoned 62 Bearish MACD 62 NASDAQ INFI 62 Sinks Lower 62 Shareholders Approve Acquisition 62 Present Preclinical Data 62 Submits Response 62 R MSCRAMM 62 NASDAQ VRUS 62 Announce Collaboration 62 Guides Inline 62 Rinat Neuroscience 62 Obtains Exclusive License 62 Movers Roundup 62 Inc Therapeutic Competitors 62 Earnings Postmortem 62 Athena Neurosciences 62 EVP Exercises Options 62 Genentech GlaxoSmithKline 62 Q3 Loss Widens 62 Exploring Strategic Alternatives 61 Submits NDA 61 Nasdaq ZGEN 61 RDYN 61 TRACON Pharmaceuticals 61 Enters Oversold Territory 61 Inc EXEL 61 http:/www.gene.com 61 Inc.today announced 61 Completes Tender Offer 61 Biotherapeutic 61 ONYX Pharmaceuticals 61 Catalyst Biosciences 61 Xenogen Corporation 61 Collaborates With 61 Successfully Completes Acquisition 61 Quark Biotech 61 Nasdaq SGEN 61 Awarded Qualifying Therapeutic 61 Corp. Nasdaq GENZ 61 Expands Portfolio 61 ZyStor Therapeutics Inc. 61 Q2 Loss Narrows 61 Webcast Presentations 61 Voluntarily Withdraw 61 Q1 Loss Narrows 61 ARIAD Pharmaceuticals 61 Director Exercises Options 61 Settles Patent Dispute 61 NASDAQ VPHM 61 Deliver Presentation 61 Announces Early Termination 60 platform HDL Mimetic 60 Pharmacueticals 60 COO Exercises Options 60 Inc. www.micromet inc.com 60 VP Exercises Options 60 SIX RO ROG 60 Initiates Clinical Trials 60 Begins Clinical Trial 60 Ridaforolimus 60 Earns Milestone Payment 60 Achieves Primary Endpoint 60 Nereus Pharmaceuticals 60 Settle Patent Dispute 60 Q2 Loss Widens 60 Terminate Merger Agreement 60 Q4 Loss Narrows 60 Announces Initiation 60 Signs Merger Agreement 60 Completes Recapitalization 60 Announce Initiation 60 ILEX Oncology 60 CEO Exercises Options 60 Therion Biologics 60 Intuit Juniper Networks 60 Biomarker Study 60 Completes Buyout 60 BIOTECHNOLOGY SOURCE 60 Inc. OTCBB MNDP 60 Nasdaq CYTX 60 Endures Analyst Downgrade 60 Stockholders Approve Merger 60 Shares Plunged What 60 Range Tightening 60 Awarded Patents 60 Post Earnings Checkup 60 Bearish Pressure Building 60 Buys Majority Stake 59 Q4 Loss Widens 59 Attracting Bullish Investors 59 DayTradersDigest.com Profiles 59 Settle Patent Litigation 59 Thewallstreetleader.com Profiles 59 Gets FDA Clearance 59 Incyte Genomics 59 Rule Breakers pick 59 PHRM 59 visit http:/www.mannkindcorp.com 59 please visit www.dyax.com 59 Cytokine PharmaSciences 59 Renews Relationship 59 Momenta Pharmaceuticals MNTA 59 Vaccine Adjuvant 59 Veronate R 59 Finalizes Acquisition 59 Inc. Nasdaq AMGN 59 Nasdaq BIIB 59 FDA Clears 59 Nasdaq TARG 59 Peggy Pinkston 59 Bullish Engulfing Formed 59 Earnings Scorecard 59 Q2 Adj 59 Tech DVAX 59 Commences Phase 59 Metabolic Disease 59 Observation Features 59 Successfully Completes Phase 59 Invites Investors 59 Submits Supplemental 59 Proposed Buyout 59 Traversa Therapeutics 59 NASDAQ RNAI 59 Nasdaq PGNX 59 www.palatin.com 59 Announces Definitive Agreement 59 Inc MEDX 59 Announces Dosing 59 Q2 Profit Surges 59 Settles Patent Litigation 59 Therapeutic Competitors companiesandmarkets.com adEgemonye 59 Ventures Invests 59 Conference Call TRANSCRIPT 59 Q1 Loss Widens 59 Upside Looming 59 Put Volume Surges 59 Q1 Adj 59 visit http:/www.PAREXEL.com 59 please visit http:/www.vandapharma.com 59 Roche OTC RHHBY 59 CFO Exercises Options 59 Corporation NasdaqGS 59 CTRX 59 Announces Presentation 59 Nasdaq CGEN 59 Guides Below 59 Traders Hedging Bets 59 SWOT Analysis Aarkstore Enterprise 59 programs visit http:/www.bionovo.com 59 Shareholders Approve Merger Agreement 59 MBRX 59 Novartis Organon 59 Beats Raises Guidance 59 staphylococcal vaccines 59 Agouron Pharmaceuticals 59 Successfully Concludes 59 Raven Biotechnologies 58 Expand Collaboration 58 Inc. OTCBB APNS 58 Dealmaking Profile 58 Restructures Debt 58 Completes Expansion 58 Makes Bearish 58 PROFILE CO 58 CybeRelease Decliners 58 Files Investigational 58 Corp. GERN 58 Closes Acquisition Of 58 Nasdaq CTIC 58 Antibody Drug Conjugate 58 Licenses Patents 58 Inc SPPI 58 Nasdaq ZIOP 58 Nasdaq THLD 58 KAI Pharmaceuticals 58 Announces Additions 58 Announces Poster Presentations 58 Merck OSI Pharmaceuticals 58 Achieves ISO #:# Certification [002] 58 Systemic Delivery 58 Merck Serono Nycomed 58 Completes Financing 58 Explore Strategic Alternatives 58 ARYX 58 Restructures Operations 58 Announces Organizational Changes 58 Secures Financing 58 Reports Receipt 58 Nasdaq MITI 58 Exploit collaboration 58 CEO Discusses Q1 58 Naglazyme R 58 Regains Full 58 hyaluronidase enzyme 58 FoldRx Pharmaceuticals Inc. 58 Sanofi Aventis Schering Plough 58 Corp. AMEX CVM 58 Finalizes Sale 58 Kiadis 58 JAK2 Inhibitor 58 Predix Pharmaceuticals 58 Receives Tentative Approval 58 Nasdaq MRNA 58 NASDAQ PACB 58 Alnylam Nasdaq ALNY 58 Nasdaq SPPI 58 Nasdaq RXII 58 www.micromet inc.com 58 NYSE WYE 58 Boehringer Ingelheim MedImmune 58 Approaching Resistance 58 Kosan dependence 58 quotes/comstock/# * 58 Buy Privately Held 58 MEDAREX 58 Trastuzumab DM1 58 Candlesticks Bearish Engulfing 58 Nasdaq AVNC 58 EMD Biosciences Inc. 58 Beats Estimates Analyst Blog 58 Taglich Brothers Initiates Coverage 58 Nasdaq ANPI 58 Shares Popped What 58 Announces Adjournment 58 Sirna Therapeutics StrataCom 58 Announces Divestiture 58 NASDAQ ENMD 58 Idera Pharmaceuticals 58 PRODUCT SOURCE 58 NASDAQ MYRX 58 pralatrexate injection folate analogue 58 Q4 Profit Surges 58 Premarket Roundup 58 TolerRx 58 oncolytic virus therapies 58 developing Zerenex ferric 58 Nasdaq AMGN 58 Announces Discontinuation 58 Crosses Below 58 Tibotec BVBA 58 NASDAQ ISIS 58 Agios Pharmaceuticals 58 Namenda Memantine HCl 57 Receives Clearance 57 Narrows Guidance 57 Nasdaq CRXX 57 Nasdaq PANC 57 Nasdaq LEXG 57 CEO Discusses F#Q# [001] 57 developing chemokine 57 Nasdaq ONXX 57 Deloitte commends 57 Schedules 3Q 57 antisense inhibitors 57 Small Molecule Drug 57 http:/www.sunesis.com 57 Nasdaq IDIX 57 Nasdaq HALO 57 Inc OSIP 57 AllPennyStocks.com Spotlights 57 Xcytrin R 57 Announce Early Termination 57 Nasdaq ALXA 57 Mintz Levin Represents 57 Amira Pharmaceuticals 57 Pharma Merck Serono 57 Array Biopharma 57 Announces Tentative Approval 57 Initiates Phase 57 Small Molecule 57 Achieves Positive 57 Inc. NASDAQ SIRT 57 Therapeutic Antibody 57 Dr. Drakeman 57 Xoma Ltd 57 Inc MLNM 57 Ingenium Pharmaceuticals AG 57 Posts Wider 57 Maxy G# 57 Other OTC MNDP 57 Q1 Profit Surges 57 Dynogen Pharmaceuticals 57 Therapeutic Competitors Report 57 Acquire Privately Held 57 Puts Sold 57 Bayer Boehringer Ingelheim 57 Announces Stock Buyback 57 NASDAQ MIPI 57 www.biogenidec.com 57 Successfully Closes 57 Identifies Key 57 visit http:/www.martek.com 57 Sets Third Quarter 57 Receives Complete Response 57 NASDAQ. 57 MARKETING AGREEMENTS PRODUCT SOURCE 57 Receives Fast Track 57 Identifies Potential 57 Albugon 57 Immunotherapeutic 57 Stockholders Approve Merger Agreement 57 Inc. Nasdaq IMGN 57 Sets Second Quarter 57 Immunex Corporation 57 Pervasis Therapeutics Inc. 57 visit www.genenews.com 57 CybeRelease Gainers 57 Inc AFFX 57 NewsBite Downgrade Puts Pressure 57 Develops Innovative 57 OSIR 57 Medisorb ® 57 Bullish Average Crossover 57 Nasdaq IMGN 57 Nasdaq CYCC 57 Nasdaq XTLB 57 Remains Neutral 57 exclusive sublicense 57 Drug Fails 57 Nasdaq ENMD 57 www.celera.com 57 please visit http:/www.sunesis.com 57 CONFERENCE CALLS SOURCE 57 Supernus Pharmaceuticals 57 CFO Resigns 57 MSCRAMM ® 57 Inc. NASDAQ ZLCS 57 Inc AMGN AMGN 57 TTGT 57 Regains NASDAQ 57 KRYSTEXXA TM pegloticase 57 OTCBB GNTA 57 Receives NASDAQ 57 Nasdaq ACHN 57 Inc CEPH 57 Changes Ticker Symbol 57 Net Loss Narrows 57 NASDAQ NUVO 57 Akebia Therapeutics 57 GENR 56 NASDAQ MEDI 56 Inc. LATEST NEWS 56 Exec Exercises Options 56 BAYRY 56 Inc. Nasdaq SLXA 56 Q3 Adj 56 Vysis 56 please visit www.metabolon.com 56 Nasdaq ACOR 56 Ups Guidance 56 Inc. NASDAQ ATHX 56 Visit www.BASInc.com 56 please visit www.lexpharma.com 56 Nasdaq OSIR 56 Explores Strategic Alternatives 56 www.enteromedics.com 56 TheWallStreetLeader.com Profiles 56 Inc. NASDAQ AMGN 56 Settles Patent Suit 56 NASDAQ IDIX 56 www.schering plough.com 56 Valera Pharmaceuticals 56 Posts Wider Loss 56 Renews Partnership 56 Delivers Next Generation 56 Daytradersdigest.com Profiles 56 Enzon Pharmaceuticals Inc 56 NASDAQ GTCB 56 NASDAQ SPPI 56 proprietary intranasal insulin 56 Phase 2b Clinical Trial 56 Bullish Technical Alert 56 CureDM 56 Inc. NASDAQ NVAX 56 Granted Orphan Drug 56 Strengthens Position 56 Nasdaq DIGE News 56 Ltd. OTCBB IMUC 56 Corp GENZ 56 s crizotinib ZAH 56 Bearish Speculation 56 MONSTERSTOX.COM Monsterstox.com 56 IDEC Pharmaceuticals 56 NASDAQ DIGE 56 Smith Kline Beecham 56 CGRB 56 Enters Into Collaboration 56 Inc. Attracting Bullish 56 NASDAQ ALNY 56 Inc. NASDAQ MITI 56 Canaccord Genuity Maintains Hold 56 Inc. NASDAQ EVVV 56 Announces Upcoming Investor 56 Reacquires 56 Showcases Next Generation 56 Eyetech Pharmaceuticals 56 non nucleoside inhibitor 56 lead molecular radiotherapeutic 56 targeted anticancer therapies 56 Nasdaq VNDA 56 Dividend Yield Outperforms 56 Stratacom 56 selective estrogen receptor modulator 56 Lowers Guidance 56 Nasdaq HGSI 56 NASDAQ VVUS 56 Guides Above 56 NASDAQ SNTA 56 Posts Narrower Loss 56 ROSG 56 DermTech International 56 MSLP.OB 56 pharma.com 56 Inc. OTCBB BCLI 56 Submits Investigational 56 NASDAQ CALP 56 Inc XNPT 56 Nasdaq AGEN 56 TRADESHOW SOURCE 56 Strengthens Leadership 56 Completes Purchase Of 56 Inc. NASDAQ MBLX 56 PathoGenesis 56 OTCBB IMNR 56 OTCBB IBPM 56 Q1 Profit Decreases 56 Gendux AB 56 Trellis Bioscience 56 Rule Breakers selection 56 developing Surfactant Replacement 56 Inc. NASDAQ GNVC 56 Inc. Nasdaq TRMS 56 Investigational Compound 56 please visit http:/www.astrazeneca-us.com 56 Nasdaq BPAX 56 Launches Generic Version 56 Q3 Profit Soars 56 Drug Candidate 56 AMEX KAL 56 Regains Compliance With 56 Red Hat RightNow Technologies 56 Locked Nucleic Acid 56 FDA APPROVES 55 OTCBB IMUC 55 Personalized Immunotherapy 55 Ibis Biosciences 55 Receives Notice Related 55 Bone Biologics 55 Genentech Wyeth Pharmaceuticals 55 NASDAQ IMGN 55 Tokai Pharmaceuticals 55 Kelly Luethje #-#-# 55 www.medimmune.com 55 Psoriasis Drug 55 Pathway Diagnostics 55 INDICATED LOWER 55 Q3 Profit Surges 55 AMEX PTN 55 Celebrates Opening 55 -Pahuta 55 Canaccord Genuity Reiterates Buy 55 Patent Covering 55 BFRM 55 TheNewsWire Gainers 55 Other OTC MNDP.PK 55 +#-#-#-# x# [003] 55 Relocates Corporate Headquarters 55 Moving Average Crossover Alert 55 ACLARA BioSciences 55 dutogliptin 55 Quark Pharmaceuticals 55 Corp EPCT 55 INDICATED HIGHER 55 Inc SEPR 55 Alnylam Pharmaceuticals Nasdaq ALNY 55 FivePrime Therapeutics 55 www.gene.com 55 PWRM.OB 55 Corp. NASDAQ CYTR 55 Novel Antibody 55 Pegloticase 55 Corp. PHRM 55 NASDAQ REGN 55 Nasdaq THRX 55 Senior VP Exercises 55 Canaccord Genuity Maintains Buy 55 Meets Primary Endpoint 55 Alnylam Pharmaceuticals ALNY 55 Epoch Biosciences 55 Adventrx Pharmaceuticals 55 molecular chaperone regulation 55 RGEN 55 Cephalon GlaxoSmithKline 55 Drug Shows Promise 55 Frankfurt XMP 55 TNGN 55 Therapeutic Competitors 55 Skymark Research Initiates Independent 55 visit www.targanta.com 55 Hydra Biosciences 55 Ercole Biotech 55 NASDAQ AFFY 55 Xenon Pharmaceuticals 55 Ception Therapeutics 55 Inc. NASDAQ NOVC 55 Oxis International 55 Announce Interoperability 55 http:/www.palatin.com 55 Exec Joins 55 Nasdaq HLCS 55 Calls Purchased 55 MOVIPREP R 55 NRGN 55 CAMBRIDGE Mass. Biotechnology 55 Taiho Pharmaceutical 55 Pharmaceuticals Initiates 55 Begins Tender Offer 55 TSX CTI 55 PRN FDA Approves 55 Reports Inducement Grants 55 Terminates Merger Agreement 55 Nasdaq MOGN 55 Nasdaq DVAX 55 CEO Discusses F#Q# [002] 55 Corporation GENZ 55 Cerexa Inc. 55 NASDAQ INCY 55 NASDAQ ACOR 55 Exherin 55 Lexicon Pharmaceuticals 55 Adamis Pharmaceuticals 55 R sorafenib tablets 55 Inc. NASDAQ ORXE 55 Acceleron Pharma Inc. 55 Shares Changing Hands 55 NASDAQ ONXX 55 please visit http:/www.supergen.com 55 Merrimack Pharmaceuticals 55 Nasdaq AVNR 55 Craig Tooman 55 Antigenics NASDAQ AGEN 55 3Q Loss Widens 55 Boosts Guidance 55 Inc. Nasdaq ABGX 55 Takeda Kyowa Hakko Kirin 55 Crosses Above 55 Nasdaq ABII 55 NASDAQ BMRN 55 Biologics Manufacturing 55 Milestone Payments 55 Transcept Pharmaceuticals 55 www.antarespharma.com 55 Initiate Clinical Trial 55 Acceleron Pharma 55 Alder Biopharmaceuticals 55 CRXL 55 AlgoRx 55 Retains CCG Investor Relations 55 Nasdaq ALNY 55 Corp. IVGN 55 Q4 Profit Plunges 55 Named Platinum Sponsor 55 Inc. Kurs Chart 55 please visit http:/www.atherogenics.com 55 Nasdaq APPY 55 SmarTrend Diagnostic Substances 55 please visit www.middlebrookpharma.com 55 ENZN 55 Combination REOLYSIN R 55 Completes Restructuring 55 NV Organon 55 molecular therapeutics immunotherapies 55 Nasdaq PPHM clinical 55 Q2 Profit Plunges 55 www.micromet.com 55 Vical Incorporated 55 #.# ohne Zeitinformationen 55 Secures Additional 55 Nasdaq PARD 55 OSI commercializes Macugen 54 Nasdaq MAXY 54 4Q Profit Doubles 54 glucokinase activator 54 Nasdaq NPSP 54 Closes Second Tranche 54 Options Brief 54 Epiphany Biosciences 54 Shows Promise Against 54 EVP Sells 54 Nasdaq MNKD focused 54 Discusses Q4 54 Co BRM.BE holdings 54 Inc FRX 54 Bristol Myers Squibb Celgene 54 CYCLOSET ® 54 NASDAQ MOGN 54 Q4 Profit Soars 54 Announce Reseller Agreement 54 http:/www.schering-plough.com/ 54 ASX PGL 54 SNMX 54 Invitrogen Nasdaq IVGN 54 LGND 54 Milestone Payment 54 Corp. BVF CN 54 Inc. NASDAQ SUPG 54 Receives Funding 54 Investigational Treatment 54 Partnering Agreements 54 Takeda Kyowa Hakko 54 ICOS Corporation 54 Laboratories Rahway NJ 54 Aphton Corporation 54 www.biosite.com 54 Retains Leading 54 Settles Patent Lawsuit 54 NASDAQ EMIS 54 Perlegen Sciences 54 ONI Systems 54 LEAD Therapeutics 54 RNAi Therapeutics 54 NYSE Amex PBTH 54 Inc SQNM 54 pharmacogenomic translational research 54 Files Patent Infringement Lawsuit 54 IMiDs ® 54 Phase III multicenter 54 Corporation GENZ GENZ 54 AVEO Pharmaceuticals 54 Aspreva Pharmaceuticals Corporation 54 Completes Reorganization 54 Dyax logo 54 proprietary intravenous formulation 54 NASDAQ PPDI 54 Investigates Proposed Acquisition 54 researches develops licenses 54 Taligen Therapeutics 54 Inc CLDA 54 Inc POZN 54 NGSX 54 Q4 Adj 54 Consulting Fees Honoraria 54 XenoPort NASDAQ XNPT 54 essential thrombocythemia ET 54 IMRX 54 NASDAQ SGEN 54 1Q Profit Triples 54 TKPHF 54 Nasdaq BMRN 54 Discusses Q3 54 Trubion Pharmaceuticals TRBN 54 Cerenis Therapeutics 54 5 HT2C 54 Inc.David 54 Inc. OCTBB 54 Idenix Novartis 54 NASDAQ NRGN 54 Nasdaq AMAG 54 Holds Annual Meeting 54 Second Quarter Earnings Preview 54 Bullish Speculation 54 http:/www.pharmacopeia.com 54 OTC BB PVCT 54 Sanofi NYSE SNY 54 NASDAQGM 54 Commenced Against 54 Demonstrates Sustained 54 Ironwood Pharmaceuticals 54 Streamlines Operations 54 CONTINUES LOWER 54 Receives Positive Opinion 54 BioRexis 54 Neuronyx Inc. 54 Nasdaq IDEV 54 FY# Loss Widens 54 OTCBB HXBM developer 54 romazarit 54 symbol AVXL 54 GSK '# 54 ImmuCell Corporation 54 AMEX RGN 54 www.shamrockstocks.com About 54 ENZON 54 Nasdaq MBRX 54 Targanta Therapeutics Corporation 54 Achieves Record Quarterly 54 Receives Anticipated 54 Avila Therapeutics 54 Given Outperform Rating 54 Achillion Pharmaceuticals 54 Nasdaq TRGT 54 NASDAQ INSM 54 NASDAQ LIPD 54 apricitabine ATC 54 Becomes Wholly Owned Subsidiary 54 QLTI 54 Paradigm Genetics 54 www.cellgenesys.com 54 Inc. DNA.N 54 Chipscreen 54 Nasdaq ENZN 54 Commercialize Novel 54 Prednisporin 54 Inc. Nasdaq MAXY 54 novel MetAP 2 54 NASDAQ PFWD 54 Inc. NASDAQ TRGT 54 NASDAQ NURO 54 Unveils Enhancements 54 ALNY 54 Vitrasert R 54 Boehringer Ingelheim Bristol Myers 54 Signs Reseller Agreement 54 Inc. Nasdaq SEPR 54 NasdaqSC ASTM 54 #.#M outstanding Pharmaceuticals 54 CancerVax Corporation 54 Aloxi ® 54 rxRNA 54 Nasdaq RDEA 54 SWOT Analysis www.companiesandmarkets.com adds 54 Insmed Incorporated 54 PharmaVitae Profile 54 Nasdaq PHRM 54 NuRx 54 visit www.FRX.com 54 Wellstat 54 Adnexus Therapeutics 54 Boosts Estimates 54 Salmedix 54 Sankyo Pharma 54 NASDAQ GXDX 54 SPL# Gel vaginal microbicide 54 www.vivus.com 54 Inc. Nasdaq INSM 54 Bearish Average Crossover 54 translational genomics 54 CRXX 54 sanofi aventis GlaxoSmithKline 54 Rule Breakers recommendation 54 technology visit http:/www.genmab.com 54 HDL Selective Delipidation 54 Mpex Pharmaceuticals 54 OTCBB AMAR 54 Prostate Cancer Vaccine 54 Virion Systems 54 outlicensed 54 Scripps Genomic Medicine 54 Nasdaq CLDA 54 OTCBB PYTO 54 4Q Profit Jumps 53 Receives Notification From 53 Nasdaq RIGL 53 Corixa Corporation 53 Extends Capabilities 53 LTBR 53 2Q Loss Narrows 53 derivatives Radilex TM 53 :/ finance.yahoo.com q 53 Nasdaq MITI biopharmaceutical 53 Ophthotech 53 GlaxoSmithKline MedImmune 53 NASDAQ LJPC 53 Pdl Biopharma Inc 53 Crofelemer budesonide foam 53 SpeBio joint venture 53 Releases Next Generation 53 Co BMY 53 CombinatoRx Incorporated 53 Inhale Therapeutic Systems 53 VRUS 53 GTC NASDAQ GTCB 53 #M MarketCap [002] 53 Inc. F#Q# Qtr 53 Regulus Alnylam 53 Advanced Inhalation 53 FORMA Therapeutics 53 Tibotec Virco 53 Signs Multiyear Agreement 53 Q4 Profit Jumps 53 Inc. NASDAQ IDMI 53 Analysts Upgrades Downgrades 53 Senomyx SNMX 53 CIMZIA r 53 Wyeth Enbrel 53 sanofi aventis Bayer Schering 53 PFIZER INC. 53 Sun Microsystems Symantec Verisign 53 Nasdaq EPCT 53 Copegus R 53 Posts 1Q Profit 53 Inc. NASDAQ MLNM 53 Lung Cancer Drug 53 BayStreet.ca Research Alert 53 Arqule 53 Praecis Pharmaceuticals 53 NASDAQ OMER 53 Luveris R Ovidrel R 53 Unveils Enhanced 53 markets COLAZAL 53 Inc. Nasdaq MITI 53 NASDAQ ONTY 53 Quark Biotech Inc. 53 Webcast Annual Meeting 53 Regeneron Pharmaceuticals 53 Xytis 53 Oral Suspension USP 53 Lexicon Genetics 53 markets Testim ® 53 Isis Pharma 53 RELOVAIR ™ 53 Vicuron Pharmaceuticals 53 Inc.announced 53 Vitamin D analogue 53 VIVUS Announces 53 NasdaqCM PSTI DAX PJT 53 Astex Therapeutics 53 Novartis Novo Nordisk 53 NASDAQ DSCO 53 Inc.John 53 experimental antibiotic Trovan 53 Announces Partial Redemption 53 COLAZAL R 53 NASDAQ SGMO 53 Q1 Profit Soars 53 ARCA biopharma Inc. 53 BNVI 53 thalidomide Thalomid 53 NASDAQ VRNM 53 Owlstone Nanotech Inc. 53 Syndax Pharmaceuticals Inc. 53 Options Trader Alert 53 www.bms.com 53 Nasdaq SCLN 53 Mr. Pilnik 53 FDA Approves Generic 53 Q2 Profit Decreases 53 Alligator Bioscience AB 53 FOLOTYN ® 53 AviaraDx 53 NeoGenesis 53 Ascenta Therapeutics 53 MacDougall Biomedical Communications 53 Celera CRA 53 commercializing Loramyc ® 53 Idenix Pharmaceuticals IDIX 53 Roche Boniva 53 RGDX 53 DVAX 53 Selects Camstar 53 Ascent Biomedical 53 Femring ® 53 Small Molecules 53 INCY 53 Analyst Actions 53 Biomarin 53 Gelesis 53 Xanthus Pharmaceuticals Inc. 53 Demonstrates Positive 53 Webcast Discussion 53 Guides FY# Quick Facts 53 IG TEC ;) CO 53 Gonal f R 53 Archemix Corp. 53 Inc. OTCBB SPRX 53 Berlex Biosciences 53 Genaissance Pharmaceuticals Inc. 53 Motorola Invests 53 Idenix Pharmaceuticals 53 Nasdaq SLXP 53 Neurome 53 Nasdaq CRME 53 Forma Therapeutics 53 Confirms Significant 53 addressing idiopathic pulmonary 53 FDA Accepts 53 NASDAQ OGXI 53 MOGN 53 Novartis Biogen Idec 53 www.ucb.com 53 Inc. OTCBB OXIS 53 Xenoport Inc. 53 Corp. ADLR 53 Aegerion Pharmaceuticals Inc. 53 Inc. OTCBB CYKN 53 NASDAQ ADLR 53 Inc. NASDAQ SGEN 53 MEMY 53 Botaneco Specialty Ingredients 53 OTCStockExchange.com Stock Alert 53 TSPT 53 narrows Quick Facts 53 Zelos Therapeutics 53 SMMX 53 Penwest Pharma 53 Teva Provides Update 53 EPIX Pharmaceuticals Inc. 53 Signs Option Agreement 53 Evaluate Strategic Alternatives 53 Inc. Nasdaq CRTX 53 NASDAQ VNDA 53 Nasdaq SOMX 53 Trimeris NASDAQ TRMS 53 Inc NVAX 53 NASDAQ ARRY 53 Christine Cassiano 53 Dianon Systems 53 Amex PTN 53 Files Annual Report 53 Atripla combines 53 NASDAQ TSPT 53 NASDAQ PCYC 53 Fleishman Hillard +#-#-#-# 53 PHARM 53 OTCBB CTIX 53 CDXS 53 Abstract Accepted 53 Alnylam ALNY 53 Successfully Treats 53 Indevus Pharmaceuticals 53 biomarker Septin 9 53 Ups Bid 53 Squibb Eli Lilly 53 Corautus Genetics 53 GENZYME 53 Nasdaq NRGN 53 Paratek Pharmaceuticals Inc. 53 LLY Short Term 53 Adenosine Therapeutics 53 Inc. NASDAQ OXGN 53 ADVERTISING MARKETING SOURCE 53 Alnara Pharmaceuticals 53 NASDAQ eMediaWorld.com mw http 53 Qiagen NASDAQ QGEN 53 Demonstrate Innovative 53 NASDAQ VRTX 53 NASDAQ TLCR 53 ONCY 53 NASDAQ OSCI 53 Nasdaq MNKD focuses 53 HIV integrase inhibitor 53 ATRN